Q32 Bio Inc. ( QTTB) - Key Metrics
QTTB Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.44 | -$0.15 | -$0.15 |
| 2026Q1 | $0 | -$0.54 | -$0.45 | -$0.45 |
| 2025Q4 | $4.07 | $4.37 | -$0.47 | -$0.47 |
| 2025Q3 | $0 | -$0.60 | -$0.35 | -$0.35 |
| 2025Q2 | $0 | -$0.78 | -$0.87 | -$0.87 |
QTTB Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -7.24 |
| 2026Q1 | 0% | -2.97 |
| 2025Q4 | 0% | 0.19 |
| 2025Q3 | 0% | -0.83 |
| 2025Q2 | 0% | -0.48 |
QTTB
Price: $15.86
52 week price:
Earnings Per Share: 3.14 USD
P/E Ratio: 4.91
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 458.7 million